Theraclone Sciences and University of Texas MD Anderson Cancer Center have jointly formed the oncology startup, which has raised $9.5m in series A capital.

Aberdeen spinout TauRx raises $135m to bring its dementia treatment through Phase 3 trials.

Theraclone Sciences and University of Texas MD Anderson Cancer Center have jointly formed the oncology startup, which has raised $9.5m in series A capital.

Baxter and Boston Scientific both participated in a series C round for the kidney disease-focused medical device maker, which has now raised $27m altogether.

The Providence Health and Services-backed company operates a patient feedback management platform to help healthcare providers deliver a better service.

Fidelity Biosciences is set to join forces with a Devonshire Investors fund to become a new FMR-owned healthcare-focused investor called F-Prime Capital.

The AARP Innovation Fund will target startups developing technologies and services for customers aged 50 and above.

Tunitas Therapeutics, which is working on treatments for allergic diseases such as asthma, has closed a series A round co-led by WuXi PharmaTech.